Metraipolis › archive › dc_de2399450ff5
Efficacy and safety of DMB-I (latrepirdine) therapy in mild to moderate dementia in Alzheimer's disease: results of a multicenter, double-blind, randomized,… — Europe PMC PMID:42141012
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42141012
- DOI
- 10.1038/s41598-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T06:13:00.985Z
- SHA-256 of the archived text
1248fdee637f24dbdbbd19d33ecf5a03108a4693ddf8cb9046ecaf0346ebcb25- Stable URL of this page
https://metraipolis.com/documento/dc_de2399450ff5
How to cite
Efficacy and safety of DMB-I (latrepirdine) therapy in mild to moderate dementia in Alzheimer's disease: results of a multicenter, double-blind, randomized,… — Europe PMC PMID:42141012 — Europe PMC (en), https://europepmc.org/article/MED/42141012 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de2399450ff5 (Metraipolis archive dc_de2399450ff5, sha256 1248fdee637f24dbdbbd19d33ecf5a03108a4693ddf8cb9046ecaf0346ebcb25)
BibTeX
@misc{dcde2399450ff5,
title = {Efficacy and safety of DMB-I (latrepirdine) therapy in mild to moderate dementia in Alzheimer's disease: results of a multicenter, double-blind, randomized,… — Europe PMC PMID:42141012},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42141012},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de2399450ff5; sha256 1248fdee637f24dbdbbd19d33ecf5a03108a4693ddf8cb9046ecaf0346ebcb25},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42141012. Agents can read the archived copy with the MCP tool read_document.